BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mikulic D, Mrzljak A. Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy. World J Clin Cases 2021; 9(20): 5398-5407 [PMID: 34307593 DOI: 10.12998/wjcc.v9.i20.5398]
URL: https://www.wjgnet.com/1007-9327/full/v9/i20/5398.htm
Number Citing Articles
1
Ngee‐Soon Lau, Mark Ly, Kasper Ewenson, Shamus Toomath, Hayden Ly, Nicole Mestrovic, Ken Liu, Geoff McCaughan, Michael Crawford, Carlo Pulitano. Indocyanine green: A novel marker for assessment of graft quality during ex situ normothermic machine perfusion of human liversArtificial Organs 2024; 48(5): 472 doi: 10.1111/aor.14696
2
Ying-Ying Cao, Kai Guo, Rui Zhao, Yuan Li, Xiao-Jing Lv, Zi-Peng Lu, Lei Tian, Shuai Ren, Zhong-Qiu Wang. Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinomaDIGITAL HEALTH 2023; 9 doi: 10.1177/20552076231179007
3
Shadi Katou, Anna Silvia Wenning, Pauline Aeschbacher, Haluk Morgul, Felix Becker, Andreas Pascher, Beat Gloor, Benjamin Strücker, Andreas Andreou. Resection margin status at the portomesenteric axis may not determine oncologic outcome after pancreaticoduodenectomy for lymph node-positive pancreatic ductal adenocarcinomaSurgery 2023; 174(1): 91 doi: 10.1016/j.surg.2023.03.007
4
Hong-Yu Wu, Jin-Wei Li, Jin-Zheng Li, Qi-Long Zhai, Jing-Yuan Ye, Si-Yuan Zheng, Kun Fang. Comprehensive multimodal management of borderline resectable pancreatic cancer: Current status and progressWorld Journal of Gastrointestinal Surgery 2023; 15(2): 142-162 doi: 10.4240/wjgs.v15.i2.142